High hydrostatic pressure (HHP) technology is a physical method for inactivating tissue. We reported that nevus specimens were inactivated after HHP at 200 MPa and that the inactivated nevus could be used as autologous dermis for covering skin defects. In this study, we verified the inactivation of nevus specimens using a newly developed portable HHP device which will be used in a clinical trial. Nevus tissue specimens were obtained from 5 patients (mean age 7.2 years, range 1-19). We cultured fibroblasts and nevus cells from the tissue specimens and then evaluated their inactivation after HHP at 200 MPa by confirming the attachment of the suspensions and by the live/dead staining of the suspensions, through the dissociation of the cells on chamber slides and by the live/dead staining of the remaining cells. The cells were also quantitatively evaluated by WST-8 assay. We then confirmed the inactivation of the nevus specimens after HHP using explant culture. Our results indicated that fibroblasts and nevus cells were inactivated after HHP at 200 MPa, with the exception of a small percentage of green-colored cells, which reflected the remaining activity of the cellular esterases after HHP. No cells migrated from the nevus specimens after HHP at 200 MPa. We verified the inactivation of fibroblasts and nevus cells cultured from nevus specimens, and in the nevus samples themselves after pressurization at 200 MPa using this device. This device could be used in clinical trials for giant congenital melanocytic nevi and may thus become useful in various medical fields.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000444048 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical and pathologic characteristics of inflamed juvenile conjunctival nevus and its treatment with immunosuppressant eye drops.
Jpn J Ophthalmol
November 2024
Department of Ophthalmology, Kansai Medical University, 2-5-1 Shinmachi, Hirakata, 573-1191, Osaka, Japan.
Purpose: To clarify the clinical and pathologic findings of 7 patients with inflamed juvenile conjunctival nevus (IJCN) treated with tacrolimus.
Study Design: Retrospective study.
Subjects And Methods: The medical records of 7 male patients diagnosed with IJCN between February 2007 and October 2022 at the Kansai Medical University Hospital and Ideta Eye Hospital were retrospectively reviewed.
[Significance of the preferentially expressed antigen in melanoma in discriminating the conjunctival malignant melanoma and pigmented nevus].
Zhonghua Yan Ke Za Zhi
November 2024
Zhongshan Ophthalmic Center, Sun Yat-sen University, State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, China.
Article Synopsis
- - The study examined the role of preferentially expressed antigen in melanoma (PRAME) for distinguishing between conjunctival malignant melanoma and pigmented nevus using samples from 172 patients collected from 2017 to 2024.
- - Results showed that 89.53% of malignant melanoma cases tested positive for PRAME, compared to only 1.16% in pigmented nevus cases, indicating a significant difference (p<0.05).
- - PRAME demonstrated high sensitivity (89.53%) and specificity (98.84%) as a diagnostic biomarker for conjunctival malignant melanoma, although expression did not vary significantly across different clinical stages of the disease.
SOX-10 and Melan-A Immunostaining in Areas of Focal Acantholytic Dyskeratosis and Epidermolytic Hyperkeratosis Within Dysplastic Nevi Biopsies: An Observational Study.
Am J Dermatopathol
January 2025
Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH; and.
Background: Focal acantholytic dyskeratosis (FAD) and epidermolytic hyperkeratosis (EHK) are common incidental epidermal histologic findings within dysplastic nevi biopsies. We evaluate whether areas of FAD and EHK within dysplastic nevi biopsies stain with immunostains used to characterize melanocytic neoplasms.
Methods: In this case series, a natural language search of histopathology reports from our institution in the past year (2020-2021) identified dysplastic nevus biopsies with concurrent FAD and/or EHK.
Inherited Basaloid Neoplasms Associated With SUFU Pathogenic Variants.
JAMA Dermatol
November 2024
Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Article Synopsis
- This study investigates the range of skin conditions in patients with germline SUFU pathogenic variants (PVs), focusing on their clinical and histopathologic features.* -
- Conducted across U.S. dermatology and genetics clinics over eight years, the study analyzed skin biopsy samples from five female patients aged 31-68, identifying several types of skin tumors.* -
- Findings reveal that alongside typical basal cell carcinomas, these patients exhibit various indolent skin lesions, indicating a broader range of cutaneous manifestations associated with SUFU PVs.*
Autopsy case of linear nevus sebaceous syndrome with KRAS (G12D) mutation.
Pathol Int
September 2024
Department of Regional Neonatal and Perinatal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Article Synopsis
- Linear nevus sebaceous syndrome (LNSS) is a neurocutaneous disorder linked to RAS gene mutations, affecting various organs including skin and the brain.
- A case report details the autopsy of a Japanese boy with LNSS who faced serious complications like hydrocephalus and congenital heart issues, leading to his death at six months old.
- Genetic testing revealed a KRAS G12D mutation in a skin sample but not in blood, indicating a postzygotic mutation, and autopsy findings uncovered new pathological issues such as intracranial lipomatous hamartoma.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!